Is 4-HO-MET (Metocin) Legal in New Hampshire? (2026)

Instrument

Definitions (Controlled Drug Act) -- "Controlled drug analog" definition (subparagraph VI-a) and supporting "Substantially similar in chemical structure" definition (subparagraph XXXI-a)

Source

https://gc.nh.gov/rsa/html/XXX/318-B/318-B-1.htm

Retrieved

2026-07-02

Fingerprint

619a7ad66c8cea56

318-B:1 Definitions. --

VI-a. (a) "Controlled drug analog" means a substance, however constituted, the chemical structure of which is derivative of, or substantially similar to that of a controlled drug and:

(1) Which has been shown in laboratory studies to bind with and activate the same central nervous receptors that are responsible for the psychoactive effects of a certain controlled drug or controlled drug class; or

(2) With respect to a particular person, which such person represents or intends to have similar psychoactive effects on the central nervous system as a controlled drug.

(b) "Controlled drug analog" shall not include:

(1) A controlled drug;

(2) Any substance for which there is an approved new drug application;

(3) With respect to a particular person, any substance, if an exemption is in effect for investigational use for that person under 21 U.S.C. section 355, to the extent conduct with respect to the substance is pursuant to such an exemption; or

(4) Any compound, mixture, or preparation that contains any controlled drug or controlled drug analog that is not for administration to a human being or animal, and that is packaged in such a form or concentration, or with adulterants or denaturants so that, as packaged, it does not present any significant potential for abuse.

XXXI-a. "Substantially similar in chemical structure" means that the substance in question shares a common core structure with a controlled drug, meaning that the "backbone" of the molecule is the same, and has no more than 2 points of divergence (additions, deletions, or substitutions) from the controlled drug, which may consist of a single atom or a functional group or some combination thereof. Functional groups are further defined as alkyl, alkenyl, alkynyl, ring structures (either homocyclic or heterocyclic, with or without additional attached functional groups), organic halides, alkoxy, alcohol, ether, amine, aldehyde, ketone, carboxylic acid, ester, amide, nitrile, nitro, sulfide, thiene, thioester, or thiol.

Instrument

statute

Source

https://law.justia.com/codes/new-hampshire/title-xxx/chapter-318-b/section-318-b-1/

Retrieved

2026-06-19

Fingerprint

3fbeffe6c9c96de9

**RSA 318-B:1, VI-a(a) (controlled drug analog)** — "'Controlled drug analog' means a substance, however constituted, the chemical structure of which is derivative of, or substantially similar to that of a controlled drug and: (1) Which has been shown in laboratory studies to bind with and activate the same central nervous receptors that are responsible for the psychoactive effects of a certain controlled drug or controlled drug class; or (2) With respect to a particular person, which such person represents or intends to have similar psychoactive effects on the central nervous system as a controlled drug."
— RSA 318-B:1, VI-a(a), https://law.justia.com/codes/new-hampshire/title-xxx/chapter-318-b/section-318-b-1/ (MIRROR: Justia, 2025).
**RSA 318-B:1, XXXI-a ("substantially similar in chemical structure")** — "'Substantially similar in chemical structure' means that the substance in question shares a common core structure with a controlled drug, meaning that the 'backbone' of the molecule is the same, and has no more than 2 points of divergence (additions, deletions, or substitutions) from the controlled drug, which may consist of a single atom or a functional group or some combination thereof. Functional groups are further defined as alkyl, alkenyl, alkynyl, ring structures … amine …"
— RSA 318-B:1, XXXI-a. Same URL (MIRROR: Justia).
**RSA 318-B:1, XIII (hallucinogenic drugs, anchor)** — "'Hallucinogenic drugs' are psychodysleptic drugs … Exemplary of such drugs are mescaline, peyote, psilocybin and d-lysergic acid diethylamide."
— RSA 318-B:1, XIII. Same URL (MIRROR: Justia).

Instrument

Acts Prohibited (controlled drug analog); controlled drug analog and substantially-similar-structure definitions

Source

https://www.gencourt.state.nh.us/rsa/html/xxx/318-b/318-b-2.htm

Retrieved

2026-07-20

Fingerprint

7e1ece894e0c8416

318-B:2, I. It shall be unlawful for any person to manufacture, possess, have under his control, sell, purchase, prescribe, administer, or transport or possess with intent to sell, dispense, or compound any controlled drug, or controlled drug analog, or any preparation containing a controlled drug, except as authorized in this chapter.

318-B:1, VI-a. (a) "Controlled drug analog" means a substance, however constituted, the chemical structure of which is derivative of, or substantially similar to that of a controlled drug and:
(1) Which has been shown in laboratory studies to bind with and activate the same central nervous receptors that are responsible for the psychoactive effects of a certain controlled drug or controlled drug class; or
(2) With respect to a particular person, which such person represents or intends to have similar psychoactive effects on the central nervous system as a controlled drug.
(b) "Controlled drug analog" shall not include:
(1) A controlled drug;
(2) Any substance for which there is an approved new drug application;
(3) With respect to a particular person, any substance, if an exemption is in effect for investigational use for that person under 21 U.S.C. section 355, to the extent conduct with respect to the substance is pursuant to such an exemption; or
(4) Any compound, mixture, or preparation that contains any controlled drug or controlled drug analog that is not for administration to a human being or animal, and that is packaged in such a form or concentration, or with adulterants or denaturants so that, as packaged, it does not present any significant potential for abuse.

318-B:1, XXXI-a. "Substantially similar in chemical structure" means that the substance in question shares a common core structure with a controlled drug, meaning that the "backbone" of the molecule is the same, and has no more than 2 points of divergence (additions, deletions, or substitutions) from the controlled drug, which may consist of a single atom or a functional group or some combination thereof. Functional groups are further defined as alkyl, alkenyl, alkynyl, ring structures (either homocyclic or heterocyclic, with or without additional attached functional groups), organic halides, alkoxy, alcohol, ether, amine, aldehyde, ketone, carboxylic acid, ester, amide, nitrile, nitro, sulfide, thiene, thioester, or thiol.